The FDA is planning research to inform its regulations on pharmaceutical advertising, according to the agency, including physician perceptions of risk information and the impact of ads on awareness vs. product promotion. "We've been exploring new guidelines that would recommend more focused disclosure of risk information in TV ads, to better emphasize potential side effects that are severe, serious and actionable," said FDA Commissioner Scott Gottlieb.
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.